Johnson & Johnson (JNJ) Change in Inventory (2009 - 2026)
Johnson & Johnson's (JNJ) quarterly Change in Inventory came in at $571.0 million in Q2 2026, up 11.96% year-over-year from $510.0 million in Q2 2025, and up 32.48% quarter-over-quarter from $431.0 million in Q1 2026.
Analysis
Johnson & Johnson (JNJ) Change in Inventory (2009 - 2026) Analysis & Trends
Johnson & Johnson has disclosed Change in Inventory across 18 years of filings, most recently posting $571.0 million for Q2 2026.
- In Q2 2026, Change in Inventory rose 11.96% year-over-year to $571.0 million; the TTM figure through Jun 2026 stood at $1.8 billion (up 71.87% YoY), while the FY2025 annual figure was $1.5 billion, up 28.55% from the prior year.
- Change in Inventory came in at $571.0 million for Q2 2026 at Johnson & Johnson, up from $431.0 million in the prior quarter.
- In the past five years, Change in Inventory ranged from a high of $1.3 billion in Q1 2023 to a low of -$124.0 million in Q4 2023.
- Average Change in Inventory over 5 years is $428.2 million, with a median of $411.0 million recorded in 2024.
- Year-over-year, Change in Inventory slumped 109.19% in 2023 and soared 195.21% in 2026.
- Over 5 years, Change in Inventory stood at $600.0 million in 2022, then slumped by 120.67% to -$124.0 million in 2023, then jumped by 172.58% to $90.0 million in 2024, then slumped by 48.89% to $46.0 million in 2025, then jumped by 1141.3% to $571.0 million in 2026.
- Per Business Quant data, the three most recent Change in Inventory figures were $571.0 million in Q2 2026, $431.0 million in Q1 2026, and $46.0 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 650.65 Bn | 629.89 Bn | 17.26 Bn | 571.00 Mn |
| 2 | AbbVie | 466.34 Bn | 459.82 Bn | 12.70 Bn | 143.00 Mn |
| 3 | Merck | 362.11 Bn | 355.02 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 267.81 Bn | 260.52 Bn | 11.24 Bn | - |
| 5 | Pfizer | 157.31 Bn | 145.91 Bn | 10.94 Bn | - |
| 6 | Bristol Myers Squibb | 128.75 Bn | 117.69 Bn | 9.25 Bn | 36.00 Mn |
| 7 | Sanofi | 51.80 Bn | 44.84 Bn | 10.79 Bn | - |
| 8 | Revolution Medicines | 40.91 Bn | 40.91 Bn | - | - |
| 9 | BeOne Medicines | 39.65 Bn | 34.55 Bn | 1.53 Bn | 47.15 Mn |
| 10 | Incyte | 25.18 Bn | 20.65 Bn | 1.57 Bn | 11.88 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 28, 2026 | 571.00 Mn |
| Mar 29, 2026 | 431.00 Mn |
| Dec 28, 2025 | 46.00 Mn |
| Sep 28, 2025 | 748.00 Mn |
| Jun 29, 2025 | 510.00 Mn |
| Mar 30, 2025 | 146.00 Mn |
| Dec 29, 2024 | 90.00 Mn |
| Sep 29, 2024 | 299.00 Mn |
| Jun 30, 2024 | 391.00 Mn |
| Mar 31, 2024 | 348.00 Mn |
| Dec 31, 2023 | -124.00 Mn |
| Oct 1, 2023 | 706.00 Mn |
| Jul 2, 2023 | 217.00 Mn |
| Apr 2, 2023 | 524.00 Mn |
| Jan 1, 2023 | 1.35 Bn |
| Apr 3, 2022 | 600.00 Mn |
| Oct 3, 2021 | 360.00 Mn |
| Jul 4, 2021 | 123.00 Mn |
| Apr 4, 2021 | 695.00 Mn |
| Jan 3, 2021 | -519.00 Mn |